Jackpotjoy has a 47 per cent upside, says Echelon Wealth

Despite mixed fourth quarter 2017 results, Jackpotjoy’s (Jackpotjoy Stock Quote, Chart, News: JPJ:LON, TSX:ITX) expansion plans and prospects for improved cash flow going forward merit a target raise, says Ralph Garcea, analyst with Echelon Wealth Partners, who on Wednesday reiterated his “Buy” rating and upped his 12-month target price to £13.00/C$23.00 from £12.00/C$20.00.

Online gaming company Jackpotjoy announced its Q4/17 and year ended December 31, 2017, financials on Tuesday, posting a 14 per cent year-on-year increase in revenue and increase in gaming revenue to £304.6 million, up from £266.9 million the previous year. The company reported weaker-than-expected EBITDA margins in Q4, however, as a result of higher operational expenses, with Garcea saying he expects to see slightly lower margins in H1/18 followed by margin expansion in H2/18 to above 35 per cent.

“With a mix of leading edge platforms (The Stars Group and 888/Dragonfish) and proprietary solutions (Vera&John and Gamesys), we expect growth to include the leveraging of the Casino, Poker, and Mobile offerings into the large Bingo customer base,” says the analyst in a client update. “Mobile now accounts for roughly half of total revenue and more than half of new customer acquisitions. Mobile provides >2.5x the average revenue of a desktop customer.”

Garcea sees Latin American expansion for the company, which could take it past the £350 million revenue run-rate by 2019 or sooner. As well, the analyst says that improved free cash flow exiting 2018 could mean a dividend is in the cards for 2019.

“JPJ is currently trading at a 2018E EV/Sales, EV/EBITDA, and P/E of 2.7x, 7.9x, and 7.0x, respectively, versus its Global Gaming comparables average of 3.0x, 10.1x, and 17.3x, respectively,” says the analyst.

Garcea has raised his 2018 revenue estimate from £324.6 to £335.11 and lowered his 2018 EBITDA estimate from £108.3 to £105.34.

The analyst’s “Buy” rating comes with a DCF-based target which has been raised from £12.00/C20.00 to £13.00/C$23.00, representing a projected return of 47 per cent at the time of publication.

More Cantech Gaming

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: itx
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Should you buy AMZN? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Amazon (Amazon Stock… [Read More]

15 hours ago

These cannabis stocks will benefit most from reclassification

It happened. The move that everyone in the cannabis sector was hoping for came about swiftly on the last day… [Read More]

22 hours ago

Is AMD stock a buy? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Suji Desilva has maintained his "Buy" rating on Advanced Micro Devices… [Read More]

22 hours ago

Is Wolfspeed stock still a buy?

Ahead of the company's third quarter results, Roth MKM analyst Scott Irwin has maintained his "Buy" rating on Wolfspeed (Wolfspeed… [Read More]

23 hours ago

WELL Health inks five-year deal with Microsoft

It's become one of the biggest players in the Canadian healthcare space, now WELL Health (WELL Health Stock Quote, Chart,… [Read More]

2 days ago

Is Thomson Reuters stock a buy right now?

Its stock has made a since last October, but is there more upside left in Thomson Reuters (Thomson Reuters Stock… [Read More]

2 days ago